FAQ/Help |
Calendar |
Search |
Today's Posts |
09-23-2009, 04:11 PM | #1 | ||
|
|||
Member
|
This afternoon, in NEJM, long-awaited data from the Teva rasagiline study, ADAGIO are released. There are two places where you can find additional commentary...one at PDOR. http://www.pdonlineresearch.org/news...difying-effect and additionally via a "News in Context" interview on the home page of the MJFF site. www.michaeljfox.org
Debi |
||
Reply With Quote |
"Thanks for this!" says: |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
azilect/rasagiline drug interactions from medicinenet.com | Parkinson's Disease | |||
azilect/rasagiline drug interactions on medicinenet.com | Parkinson's Disease | |||
story of MAO inhibitors--selegiline (deprenyl) and rasagiline (azilect) | Parkinson's Disease | |||
Azilect (rasagiline)...in the USA | Parkinson's Disease |